功能性胃肠病认知的改变:A.罗马Ⅰ认为功能性肠病是独立的个体;B.罗马Ⅱ—Ⅲ意识到功能性肠病存在疾病谱的重叠;C.罗马Ⅳ提出“症状表现谱”,即功能性胃肠病不是独立的疾病,而是连续而统一的[12]
1 传统泻剂 2 促分泌剂
3 其他疗法
参考文献: [1]Sayuk GS,Wolf R,Chang L.Comparison of symptoms,healthcare utilization, and treatment in diagnosed and undiagnosed individuals with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2017;112:892-9. [2]李莉,熊理守.肠易激综合征的流行病学调查.中华消化杂志,2015;35:446-50. [3] 中华医学会消化病学分会胃肠功能性疾病协作组,中华医学会消化病学分会胃肠动力学组.中国肠易激综合征专家共识意见(2015年,上海).中华消化杂志,2016;36:299-312. [4] Rome Ⅳ:The Func-tional Gastrointestinal Disorders[M]. [5]辛海威,方秀才,柯美云.功能性便秘和便秘型肠易激综合征-我们能鉴别吗?[J]. 胃肠病学和肝病学杂志,2013,22(02):158-162. [6]Irritable Bowel Syndrome:What Treatments Really Work.The Medical clinics of North America,2019,103 (1) :137-152. [7]Ford AC, et al. Am J Gastroenterol 2018; 113(Suppl 2):1-18. [8] Ford AC,et al. Am J Gastroenterol.2014 Aug;109 Suppl 1:S2-26 [9] 袁耀宗.便秘型肠易激综合征诊疗进展专家会议纪要[J] .中华消化杂志,2019,39(3): 197-198. DOI: 10.3760/cma.j.issn.0254-1432.2019.03.013 [10] 张颖慧等.神经调节药物在功能性胃肠病中的应用:罗马基金会工作小组报告解读[J].中华消化杂志,2019,39(7):499-502 [11] Bassotti G,Villanacci V,Nascimbeni R,et al.Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia[J]. Dig Dis Sci,2012,57( 1) :65-71. [12] Tack J, Drossman D A. What's new in Rome IV?[J]. Neurogastroenterology & Motility the Official Journal of the European Gastrointestinal Motility Society, 2017, 29(Suppl 1):e13053. [13]Simrén, M,Törnblom, H,Palsson, O.S,Van Oudenhove, L,Whitehead,W.E, & Tack, J. (2019). Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology. doi:10.1053/j.gastro.2019.04.019 |
|